摘要
Abstract
Objective To explore the clinical effect of Xiao'er Feire Kechuan oral liquid combined with cefaclor for oral suspension in the treatment of bronchopneumonia in children and its effect on C-reactive protein level.Methods A total of 60 children diagnosed with bronchopneumonia in Yichun Yuanzhou District Maternal and Child Health Hospital from January 2020 to December 2023 were selected as the research objects,and they were divided into control group and study group according to the random number table method,with 30 children in each group.The control group was treated with cefaclor for oral suspension,and the study group was treated with Xiao'er Feire Kechuan oral liquid on the basis of the control group.The therapeutic effect,disappearance time of clinical symptoms and signs(antipyretic time,cough disappearance time,lung rale disappearance time,chest X-ray recovery time),inflammatory factor level[C-reactive protein(CRP)]and incidence of adverse reactions(stomatitis,nasal discharge,nausea and vomiting,gastritis)were compared between the two groups.Results Compared with 73.33%of the total effective rate of the control group,the total effective rate of the study group was higher,reaching 96.67%(P<0.05).Compared with the control group,the antipyretic time,cough disappearance time,lung rale disappearance time and chest X-ray recovery time in the study group were shorter,and the CRP level was lower after treatment(P<0.05).Compared with 23.33%of the incidence of adverse reactions in the control group,the incidence of adverse reactions in the study group was lower,only 6.67%(P<0.05).Conclusion Xiao'er Feire Kechuan oral liquid combined with cefaclor for oral suspension has a definite clinical effect in the treatment of bronchopneumonia in children,which can improve their inflammatory factor level,accelerate the disappearance of clinical symptoms,and has high medication safety.关键词
小儿肺热咳喘口服液/头孢克洛干混悬剂/小儿支气管肺炎/C反应蛋白Key words
Xiao'er Feire Kechuan oral liquid/Cefaclor for oral suspension/Bronchopneumonia in children/C-reactive protein分类
医药卫生
